Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Migraine

Free Subscription 22.12.2025 4 Cephalalgia 3 Headache 1 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Cephalalgia

1. GKOUZIOTI V, Abdollahzadeh A, van den Hil F, Orlova V, et al
   Indirect crosstalk between signalling pathways activated by CGRP and Piezo1 in human iPSC-derived endothelial cells relevant to migraine.
   Cephalalgia. 2025;45:3331024251404478.
   PubMed         Abstract available
   
   
2. PASQUALETTI P, Altamura C, Fofi L, Iannone LF, et al
   Introducing the four dimensions 4D migraine scale: A composite score proposal evaluating migraine severity and treatment efficacy.
   Cephalalgia. 2025;45:3331024251398020.
   PubMed         Abstract available
   
   
3. ENGSTRAND H, Argren MB, Zwart JA, Tronvik E, et al
   The burden of high-frequency episodic migraine and chronic migraine in the population-based PopHEAD study.
   Cephalalgia. 2025;45:3331024251406103.
   PubMed         Abstract available
   
   
4. IHARA K, Pike CW, Hui G, Gombar S, et al
   Estrogen exposure from modern contraceptives and vascular risk in women with migraine: A nationwide electronic medical record database study.
   Cephalalgia. 2025;45:3331024251404924.
   PubMed         Abstract available
   
   

   
   Headache

5. MEHNERT J, Scutelnic A
   Migraine is a disorder of function: No evidence for structural alterations within the central nervous system in migraine.
   Headache. 2025 Dec 16. doi: 10.1111/head.70010.
   PubMed        
   
   
6. PARDO K, Mermelstein M, Tsur G, Yust-Katz S, et al
   Do patients with migraine and obesity receive different treatments? Insights from real-world data.
   Headache. 2025 Dec 15. doi: 10.1111/head.70011.
   PubMed         Abstract available
   
   
7. BLUMENFELD AM, Charleston L 4th, Kuruvilla D, Savage-Edwards B, et al
   OnabotulinumtoxinA treatment among diverse racial groups: Post hoc analysis of the phase 4 Chronic migraine OnabotulinuMtoxinA Prolonged Efficacy open-Label (COMPEL) trial.
   Headache. 2025 Dec 15. doi: 10.1111/head.70007.
   PubMed         Abstract available
   
   

   
   Rev Neurol (Paris)

8. VAN OBBERGHEN EK, Fabre R, Bailly L, Lanteri-Minet M, et al
   Trends in the real-world management of cluster headache patients treated by subcutaneous sumatriptan and/or oxygen in France - An analysis of the French National Social Security System Open Data over eleven years (2014-2024).
   Rev Neurol (Paris). 2025 Dec 16:S0035-3787(25)00653.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.